A Gated Community for Oncology Nurses and
Cancer Care Teams | More Info
Breast   |   Prostate   |   Lung   |   Hematology   |   Skin   |   Gastrointestinal   |   Genitourinary   |   Head / Neck   |   Brain   |   Gynecological   |   Sarcoma   |   Thyroid
Career  |  Exercise  |  Nutrition  |  Recipes  |  Survivorship  |  Symptom Management  |  Emergencies  |  Side Effects  |  Pediatrics  |  Complementary Therapies
Blog Roll
Carole McCue

Time to Break the Bullying Cycle

View Comments: Newest First | Oldest First | Threaded View
More Blogs from...
Carole McCue
Nursing instructor Carole McCue wants to know how effective religious or spiritual coping strategies are for your cancer patients.
Nursing instructor Carole McCue wants to know what steps you're taking to help patients with the rising cost of cancer treatment.
Nursing instructor Carole McCue talks about how one author demonstrated the emotional journey of cancer patients.
Carole McCue stresses the need for better screening when it comes to CAM use in the geriatric patient population.
Carole McCue wants to know your education methods for patient teaching.
Webinar Series
Tuesday, October 29, 2013 12:00 PM EDT

Presented by Ellen T. Matloff, MS, CGC , this webinar will highlight:

  • How to determine which patients require genetic counseling
  • How to help prepare your patients for the genetic counseling process
  • Testing options that are now available
  • How you can utilize this data in managing your patients and their family members

Participants will also be able to ask questions during a live question and answer period with speaker Ellen T. Matloff, MS, CGC .

Wednesday, August 28, 2013 12:00 PM EDT
Wednesday, June 26, 2013 12:00 PM EDT
Wednesday, April 10, 2013 12:00 PM EDT
Have a question or topic but don't want to write a blog? Post it on our readerboards and get feedback from the community!
stopcancer on Community-based Cancer Support Services Centers
HumptyDumpty on Family and chemotherapy
melissann512 on Oncology Nurse Navigator
FDA Approves Onivyde for Advanced Pancreatic Cancer
Marijke Vroomen Durning, RN,
10/27/2015  3
On October 22, 2015, the US Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection, Merrimack Pharmaceuticals, Inc.), in combination with fluorouracil ...
Like Us on Facebook
on Twitter
TheONC Twitter Feed